Mohs micrographic surgery in dermatofibrosarcoma protuberans allows tumour clearance with smaller margins and greater preservation of healthy tissue compared with conventional surgery: A study of 74 primary cases

British Journal of Dermatology

Volumn 172, Issue 5, 2015, Pages 1303-1307

  Serra Guillen C ^a   Llombart, B ^a   Nagore, E ^a,b   Guillen C ^a   Requena, C ^a   Traves, V ^a   Kindem, S ^a   Alcala R ^a   Rivas, N ^a   Sanmartin O ^a,b  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CHEMOSURGERY; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; DISEASE CLEARANCE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRESERVATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN DEFECT; SKIN GRAFT; SKIN SURGERY; SURFACE AREA; COMPARATIVE STUDY; DERMATOFIBROSARCOMA; ETIOLOGY; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROCEDURES; SKIN NEOPLASMS; TIME TO TREATMENT; TUMOR RECURRENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DERMATOFIBROSARCOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS; TIME-TO-TREATMENT; YOUNG ADULT;

EID: 84929129999     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13417     Document Type: Article

References (31)

1. LeBoit P, Burg G, Weedon D, et al,. Soft tissue tumours. In: World Health Organization Classification of Tumours. Pathology and Genetics. Skin Tumours (, LeBoit P, Burg G, Weedon D, Sarasin A, eds). Lyon: IARC, 2006; 229-62.
2. Cai H, Wang Y, Wu J, Shi Y,. Dermatofibrosarcoma protuberans: clinical diagnoses and treatment results of 260 cases in China. J Surg Oncol 2012; 105: 142-8.
3. Erdem O, Wyatt AJ, Lin E, et al,. Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables. Am J Dermatopathol 2012; 34: 24-34.
4. Heuvel ST, Suurmeijer A, Pras E, et al,. Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol 2010; 36: 89-94.
5. Kim M, Huh CH, Cho KH, Cho S,. A study on the prognostic value of clinical and surgical features of dermatofibrosarcoma protuberans in Korean patients. J Eur Acad Dermatol Venereol 2012; 26: 964-71.
6. Serra-Guillén C, Sanmartín O, Llombart B, et al,. Correlation between preoperative magnetic resonance imaging and surgical margins with modified Mohs for dermatofibrosarcoma protuberans. Dermatol Surg 2011; 37: 1638-45.
7. Häfner HM, Moehrle M, Eder S, et al,. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome. Eur J Surg Oncol 2008; 34: 680-6.
8. Nelson RA, Arlette JP,. Mohs micrographic surgery and dermatofibrosarcoma protuberans: a multidisciplinary approach in 44 patients. Ann Plast Surg 2008; 60: 667-72.
9. Paradisi A, Abeni D, Rusciani A, et al,. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev 2008; 34: 728-36.
10. Serra-Guillén C, Llombart B, Sanmartín O,. Dermatofibrosarcoma protuberans. Actas Dermosifiliogr 2012; 103: 762-77.
11. Matin RN, Acland KM, Williams HC,. Is Mohs micrographic surgery more effective than wide local excision for treatment of dermatofibrosarcoma protuberans in reducing risk of local recurrence? A Critically Appraised Topic. Br J Dermatol 2012; 167: 6-9.
12. Meguerditchian AN, Wang J, Lema B, et al,. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans. Am J Clin Oncol 2010; 33: 300-3.
13. Yu W, Tsoukas MM, Chapman SM, Rosen JM,. Surgical treatment for dermatofibrosarcoma protuberans: the Dartmouth experience and literature review. Ann Plast Surg 2008; 60: 288-93.
14. Weiss SW, Goldblum JR,. Fibrohistiocytic tumours of intermediate malignancy. In: Enzinger and Weiss's Soft Tissue Tumours (, Weiss SW, Goldblum JR, eds), 5th edn. Philadelphia: Mosby, Inc., 2008; 371-402.
15. Salgado R, Llombart B, Pujol RM, et al,. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies. Genes Chromosom Cancer 2011; 50: 510-17.
16. Llombart B, Monteagudo C, Sanmartín O, et al,. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumours. J Am Acad Dermatol 2011; 65: 564-75.
17. Wacker J, Khan-Durani B, Hartschuh W,. Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Ann Surg Oncol 2004; 11: 438-44.
18. Echeverría-García B, Serra-Guillén C, Nagore E, et al,. The use of a biosynthetic skin substitute in slow Mohs micrographic surgery. Dermatol Surg 2012; 38: 683-9.
19. Criscione VD, Weinstock MA,. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol 2007; 56: 968-73.
20. Gloster HM Jr,. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996; 35: 355-74.
21. Khatri VP, Galante JM, Bold RJ, et al,. Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol 2003; 10: 1118-22.
22. Parker TL, Zitelli JA,. Surgical margins for excision of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1995; 32: 233-6.
23. Martin L, Piette F, Blanc P, et al,. Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol 2005; 153: 932-6.
24. Ratner D, Thomas CO, Johnson TM, et al,. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 1997; 37: 600-13.
25. Ah-Weng A, Marsden JR, Sanders DS, Waters R,. Dermatofibrosarcoma protuberans treated by micrographic surgery. Br J Cancer 2002; 87: 1386-9.
26. Gloster HM Jr, Harris KR, Roenigk RK,. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996; 35: 82-7.
27. Dawes KW, Hanke CW,. Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins. Dermatol Surg 1996; 22: 530-4.
28. Galimberti G, Montaño AP, Kowalczuk A, et al,. Outcomes in 11 patients with dermatofibrosarcoma protuberans treated with Mohs micrographic surgery. Int J Dermatol 2012; 51: 89-93.
29. Kimmel Z, Ratner D, Kim JY, et al,. Peripheral excision margins for dermatofibrosarcoma protuberans: a meta-analysis of spatial data. Ann Surg Oncol 2007; 14: 2113-20.
30. Thomas CJ, Wood GC, Marks VJ,. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumours: the Geisinger experience. Dermatol Surg 2007; 33: 333-9.
31. Hancox JG, Kelley B, Greenway HT Jr,. Treatment of dermatofibroma sarcoma protuberans using modified Mohs micrographic surgery: no recurrences and smaller defects. Dermatol Surg 2008; 34: 780-4.